| Net Cash Provided by (Used in) Operating Activities |
$9,589 |
USD |
65% |
Q2 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$9,465 |
USD |
-66% |
Q2 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$124 |
USD |
-169% |
Q2 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$153,231 |
USD |
-2.6% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$153,231 |
USD |
-2.6% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
0% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
$454,216 |
USD |
0% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
0% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2025 |
FY 2025 |